Home › Upcoming votes › Accendra Health, Inc.
Read the proxy statement on EDGARAccendra Health, Inc.: past votes
Ballot read from the proxy statement and checked. As listed in Accendra Health, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | THE REVERSE SPLIT PROPOSAL | Board | For | — |
| 2 | THE ADJOURNMENT PROPOSAL Adjournment |
Board | For | — |
From Accendra Health, Inc.’s Form 8-K, filed May 15, 2026, for the meeting held May 14, 2026 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Mark A. Beck | 98% | — |
| Elect Director: Gwendolyn M. Bingham | 98% | — |
| Elect Director: Kenneth Gardner-Smith | 97% | — |
| Elect Director: Stephen W. Klemash | 98% | — |
| Elect Director: Teresa L. Kline | 98% | — |
| Elect Director: Edward A. Pesicka | 93% | — |
| 2. Ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 99% | — |
| 3. Non-binding advisory vote to approve the compensation of our named executive officers | 92% | — |
| (4) Approval of the Accendra Health, Inc. | 97% | — |
The five managers that reported the most shares voted at Accendra Health, Inc.’s May 14, 2026 meeting, from their Form N-PX filings. This is how they voted then; it says nothing about how they will vote this time. Every manager’s vote.
| Item | Coliseum Capital Management, LLC | Charles Schwab | Vanguard | BlackRock | Invenomic Capital Management LP |
|---|---|---|---|---|---|
| Elect Director: Mark A. Beck | — | For | For | For | — |
| Elect Director: Gwendolyn M. Bingham | — | For | For | For | — |
| Elect Director: Kenneth Gardner-Smith | — | For | For | For | — |
| Elect Director: Stephen W. Klemash | — | For | For | For | — |
| Elect Director: Teresa L. Kline | — | For | For | For | — |
| Elect Director: Edward A. Pesicka | — | For | For | For | — |
| 2. Ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending De | — | For | For | For | — |
| 3. Non-binding advisory vote to approve the compensation of our named executive officers | For | For | For | For | For |
| (4) Approval of the Accendra Health, Inc. | — | For | For | For | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.